EVANS_HEARING_AND_HEALTHC - Accounts


Company registration number 10970522 (England and Wales)
EVANS HEARING AND HEALTHCARE LIMITED
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2022
PAGES FOR FILING WITH REGISTRAR
EVANS HEARING AND HEALTHCARE LIMITED
CONTENTS
Page
Balance sheet
1 - 2
Notes to the financial statements
3 - 8
EVANS HEARING AND HEALTHCARE LIMITED
BALANCE SHEET
AS AT
31 DECEMBER 2022
31 December 2022
- 1 -
2022
2021
Notes
£
£
£
£
Fixed assets
Tangible assets
3
27,084
350,725
Current assets
Stocks
29,362
28,643
Debtors
4
14,684
4,604
Cash at bank and in hand
160,789
138,708
204,835
171,955
Creditors: amounts falling due within one year
5
(132,100)
(121,319)
Net current assets
72,735
50,636
Total assets less current liabilities
99,819
401,361
Creditors: amounts falling due after more than one year
6
(66,874)
(111,207)
Provisions for liabilities
(460)
(1,914)
Net assets
32,485
288,240
Capital and reserves
Called up share capital
100
100
Profit and loss reserves
32,385
288,140
Total equity
32,485
288,240

The directors of the company have elected not to include a copy of the profit and loss account within the financial statements.true

For the financial year ended 31 December 2022 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

EVANS HEARING AND HEALTHCARE LIMITED
BALANCE SHEET (CONTINUED)
AS AT
31 DECEMBER 2022
31 December 2022
- 2 -
The financial statements were approved by the board of directors and authorised for issue on 28 April 2023 and are signed on its behalf by:
T M Evans
Director
Company Registration No. 10970522
EVANS HEARING AND HEALTHCARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2022
- 3 -
1
Accounting policies
Company information

Evans Hearing and Healthcare Limited is a private company limited by shares incorporated in England and Wales. The registered office is Glebe Barn, 24A Church Lane, Cranford, Kettering, Northamptonshire, NN14 4AE.

1.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

1.2
Going concern

Whilst the impact of coronavirus has dissipated to some degree, the legacy of its effect continues to be felt throughout most sectors of the economy. Other matters such as supply chain issues and rising prices, particularly fuel and energy, are impacting across all businesses. Going concern is therefore an important area that the directors are keeping under close scrutiny. No immediate concerns in relation to the company’s long term future have been identified, but this area continues to be monitored. The directors are satisfied that the steps they have taken in the short term are appropriate and effective.true

1.3
Turnover

Turnover is recognised at the fair value of the consideration received or receivable for goods provided in the normal course of business, and is shown net of VAT and other sales related taxes. The fair value of consideration takes into account trade discounts, settlement discounts and volume rebates.

Revenue from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have passed to the buyer (usually on dispatch of the goods), the amount of revenue can be measured reliably, it is probable that the economic benefits associated with the transaction will flow to the entity and the costs incurred or to be incurred in respect of the transaction can be measured reliably.

1.4
Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Freehold land and buildings
2% per annum straight line
Plant and equipment
20% per annum reducing balance
Fixtures and fittings
20% per annum reducing balance
Computers
25% per annum straight line
Motor vehicles
25% per annum reducing balance

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

EVANS HEARING AND HEALTHCARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2022
1
Accounting policies
(Continued)
- 4 -
1.5
Impairment of fixed assets

At each reporting period end date, the company reviews the carrying amounts of its tangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any). Where it is not possible to estimate the recoverable amount of an individual asset, the company estimates the recoverable amount of the cash-generating unit to which the asset belongs.

Recoverable amount is the higher of fair value less costs to sell and value in use. In assessing value in use, the estimated future cash flows are discounted to their present value using a pre-tax discount rate that reflects current market assessments of the time value of money and the risks specific to the asset for which the estimates of future cash flows have not been adjusted.

Recognised impairment losses are reversed if, and only if, the reasons for the impairment loss have ceased to apply. Where an impairment loss subsequently reverses, the carrying amount of the asset (or cash-generating unit) is increased to the revised estimate of its recoverable amount, but so that the increased carrying amount does not exceed the carrying amount that would have been determined had no impairment loss been recognised for the asset (or cash-generating unit) in prior years. A reversal of an impairment loss is recognised immediately in profit or loss, unless the relevant asset is carried at a revalued amount, in which case the reversal of the impairment loss is treated as a revaluation increase.

1.6
Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost comprises direct materials.

 

Stocks held for distribution at no or nominal consideration are measured at the lower of replacement cost and cost, adjusted where applicable for any loss of service potential.

At each reporting date, an assessment is made for impairment. Any excess of the carrying amount of stocks over its estimated selling price less costs to complete and sell is recognised as an impairment loss in profit or loss. Reversals of impairment losses are also recognised in profit or loss.

1.7
Cash and cash equivalents

Cash at bank and in hand are basic financial assets and include cash in hand, deposits held at call with banks and other short-term liquid investments with original maturities of three months or less.

1.8
Financial instruments

The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

 

Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.

 

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets

Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

EVANS HEARING AND HEALTHCARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2022
1
Accounting policies
(Continued)
- 5 -
Classification of financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

Basic financial liabilities

Basic financial liabilities, including creditors and bank loans are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

 

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

 

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

1.9
Equity instruments

Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.

1.10
Taxation

The tax expense represents the sum of the tax currently payable and deferred tax.

Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

Deferred tax

Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.

 

The carrying amount of deferred tax assets is reviewed at each reporting end date and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered. Deferred tax is calculated at the tax rates that are expected to apply in the period when the liability is settled or the asset is realised. Deferred tax is charged or credited in the profit and loss account, except when it relates to items charged or credited directly to equity, in which case the deferred tax is also dealt with in equity. Deferred tax assets and liabilities are offset when the company has a legally enforceable right to offset current tax assets and liabilities and the deferred tax assets and liabilities relate to taxes levied by the same tax authority.

EVANS HEARING AND HEALTHCARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2022
1
Accounting policies
(Continued)
- 6 -
1.11
Employee benefits

The costs of short-term employee benefits are recognised as a liability and an expense.

 

The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.

 

Termination benefits are recognised immediately as an expense when the company is demonstrably committed to terminate the employment of an employee or to provide termination benefits.

1.12
Retirement benefits

Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due.

1.13
Government grants

A grant that specifies performance conditions is recognised in income when the performance conditions are met. Where a grant does not specify performance conditions it is recognised in income when the proceeds are received or receivable. A grant received before the recognition criteria are satisfied is recognised as a liability.

2
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2022
2021
Number
Number
Total
12
12
EVANS HEARING AND HEALTHCARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2022
- 7 -
3
Tangible fixed assets
Freehold land and buildings
Plant and equipment
Fixtures and fittings
Computers
Motor vehicles
Total
£
£
£
£
£
£
Cost
At 1 January 2022
346,720
913
27,215
4,749
36,948
416,545
Additions
-
0
-
0
3,070
-
0
-
0
3,070
Disposals
(475,000)
-
0
-
0
-
0
-
0
(475,000)
Revaluation
128,280
-
0
-
0
-
0
-
0
128,280
At 31 December 2022
-
0
913
30,285
4,749
36,948
72,895
Depreciation and impairment
At 1 January 2022
28,314
426
13,429
2,375
21,276
65,820
Depreciation charged in the year
2,311
98
3,102
1,187
3,918
10,616
Revaluation
(30,625)
-
0
-
0
-
0
-
0
(30,625)
At 31 December 2022
-
0
524
16,531
3,562
25,194
45,811
Carrying amount
At 31 December 2022
-
0
389
13,754
1,187
11,754
27,084
At 31 December 2021
318,406
487
13,786
2,374
15,672
350,725
4
Debtors
2022
2021
Amounts falling due within one year:
£
£
Trade debtors
9,327
244
Other debtors
5,357
4,360
14,684
4,604
5
Creditors: amounts falling due within one year
2022
2021
£
£
Bank loans
10,000
10,000
Trade creditors
66,776
55,892
Taxation and social security
47,334
42,997
Other creditors
7,990
12,430
132,100
121,319

Included within other creditors is a hire purchase balance of £nil (2021 - £3,342), secured over the asset to which it relates.

EVANS HEARING AND HEALTHCARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2022
- 8 -
6
Creditors: amounts falling due after more than one year
2022
2021
£
£
Bank loans and overdrafts
28,333
38,333
Other creditors
38,541
72,874
66,874
111,207
7
Operating lease commitments

At the reporting end date the company had outstanding commitments for future minimum lease payments under non-cancellable operating leases, as follows:

2022
2021
£
£
27,060
-
0
2022-12-312022-01-01falseCCH SoftwareCCH Accounts Production 2023.100No description of principal activityT A EvansT M Evans109705222022-01-012022-12-31109705222022-12-31109705222021-12-3110970522core:LandBuildingscore:OwnedOrFreeholdAssets2022-12-3110970522core:PlantMachinery2022-12-3110970522core:FurnitureFittings2022-12-3110970522core:ComputerEquipment2022-12-3110970522core:MotorVehicles2022-12-3110970522core:LandBuildingscore:OwnedOrFreeholdAssets2021-12-3110970522core:PlantMachinery2021-12-3110970522core:FurnitureFittings2021-12-3110970522core:ComputerEquipment2021-12-3110970522core:MotorVehicles2021-12-3110970522core:CurrentFinancialInstrumentscore:WithinOneYear2022-12-3110970522core:CurrentFinancialInstrumentscore:WithinOneYear2021-12-3110970522core:Non-currentFinancialInstrumentscore:AfterOneYear2022-12-3110970522core:Non-currentFinancialInstrumentscore:AfterOneYear2021-12-3110970522core:CurrentFinancialInstruments2022-12-3110970522core:CurrentFinancialInstruments2021-12-3110970522core:Non-currentFinancialInstruments2022-12-3110970522core:Non-currentFinancialInstruments2021-12-3110970522core:ShareCapital2022-12-3110970522core:ShareCapital2021-12-3110970522core:RetainedEarningsAccumulatedLosses2022-12-3110970522core:RetainedEarningsAccumulatedLosses2021-12-3110970522bus:Director22022-01-012022-12-3110970522core:LandBuildingscore:OwnedOrFreeholdAssets2022-01-012022-12-3110970522core:PlantMachinery2022-01-012022-12-3110970522core:FurnitureFittings2022-01-012022-12-3110970522core:ComputerEquipment2022-01-012022-12-3110970522core:MotorVehicles2022-01-012022-12-31109705222021-01-012021-12-3110970522core:LandBuildingscore:OwnedOrFreeholdAssets2021-12-3110970522core:PlantMachinery2021-12-3110970522core:FurnitureFittings2021-12-3110970522core:ComputerEquipment2021-12-3110970522core:MotorVehicles2021-12-31109705222021-12-3110970522core:WithinOneYear2022-12-3110970522core:WithinOneYear2021-12-3110970522bus:PrivateLimitedCompanyLtd2022-01-012022-12-3110970522bus:SmallCompaniesRegimeForAccounts2022-01-012022-12-3110970522bus:FRS1022022-01-012022-12-3110970522bus:AuditExemptWithAccountantsReport2022-01-012022-12-3110970522bus:Director12022-01-012022-12-3110970522bus:FullAccounts2022-01-012022-12-31xbrli:purexbrli:sharesiso4217:GBP